Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FU559
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,501
Award facts
- Contract value 100% obligated
- $30,501.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,501.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a non-set-aside contract with performance completion scheduled for December 10, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name drugs, vaccines, and medical devices across multiple therapeutic domains to support military and veteran healthcare systems. This specific award for Repatha—a cholesterol-lowering medication—demonstrates the company's continued role in delivering specialized pharmaceuticals to federal healthcare beneficiaries within the broader framework of the DLA's global pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26FU559?
SPE2DR26FU559 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FU559 worth?
The government has obligated $30,501 on SPE2DR26FU559.
Is contract SPE2DR26FU559 an order under another contract?
Yes. SPE2DR26FU559 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU559 competed?
The extent of competition for SPE2DR26FU559 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award